Other content recommended for you,

  1. A real-world retrospective cohort study in the United States: Comparing the effectiveness of tofacitinib to vedolizumab for UC.
    Dalal R.S et al., Inflammatory Bowel Diseases, 2023; Provided by Pfizer Medical Affairs
  2. Self-Similarity Breaking: Anomalous Nonequilibrium Finite-Size Scaling and Finite-Time Scaling
    Weilun Yuan et al., Chinese Physics Letters, 2021
  3. Correlation Renormalized and Induced Spin-Orbit Coupling
    Kun Jiang et al., Chinese Physics Letters, 2023
  4. Advances and Challenges of Epidemic Outbreaks in the Post-COVID-19 Era in China
    Chao Zhang et al., Infectious Diseases & Immunity, 2023
  5. Outcomes of Tofacitinib vs Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure
    Dalal R.S et al., Inflammatory Bowel Diseases, 2023; Provided by Pfizer Medical Affairs